Suppr超能文献

S292F甲状腺过氧化物酶(TPO)基因突变在三个突尼斯甲状腺激素合成障碍大家族中的分离:奠基者效应的证据

Segregation of S292F TPO gene mutation in three large Tunisian families with thyroid dyshormonogenesis: evidence of a founder effect.

作者信息

Bougacha-Elleuch Noura, Charfi Nadia, Miled Nabil, Bouhajja Houda, Belguith Neila, Mnif Mouna, Jaurge Paula, Chikhrouhou Nessrine, Ayadi Hammadi, Hachicha Mongia, Abid Mohamed

机构信息

Unité Cibles pour le Diagnostic et la Thérapie, Centre de Biotechnologie Sfax, BP 1177, 3018, Sfax, Tunisia.

Service d'Endocrinologie, CHU Hédi Chaker, Sfax, Tunisia.

出版信息

Eur J Pediatr. 2015 Nov;174(11):1491-501. doi: 10.1007/s00431-015-2550-4. Epub 2015 May 13.

Abstract

UNLABELLED

We aimed to identify causal mutation(s) in 13 patients with thyroid dyshormonogenesis (TD) from three consanguineous Tunisian families. A 12-year clinical follow-up showed phenotypic variability ranging from the presence to the absence of goiter, sensorineural deafness, and mental retardation. Genetic analysis using microsatellite markers within two candidate genes (TPO and PDS) gave evidence of linkage with the TPO gene. Sequencing of its 17 exons and their flanking intron-exon junctions revealed the previously described c.875C>T (p.S292F) mutation in homozygous state. No additional mutations were found in either a 900 bp of the TPO gene promoter or PDS gene. In silico analysis showed that p.S292F mutation might reduce the catalytic cavity of the TPO which would restrict access of a potential substrate to the catalytic pocket. Using 4SNPs and one microsatellite marker in the TPO gene, an associated haplotype: G-C-G-G-214 was found, giving evidence of a founder mutation.

CONCLUSION

This is the first description of a TD causing mutation in Tunisia and thus may help to develop a genetic screening protocol for congenital hypothyroidism in the studied region. Although structural modeling suggested a pathogenic effect of this mutation, functional studies are needed. Additional causing and/or modifier genes, together with late diagnosis could explain the clinical variability observed in our patients.

摘要

未标记

我们旨在鉴定来自三个突尼斯近亲家庭的13例甲状腺激素合成障碍(TD)患者的致病突变。一项为期12年的临床随访显示,表型存在差异,从有甲状腺肿、感音神经性耳聋和智力迟钝到无这些症状。使用两个候选基因(TPO和PDS)内的微卫星标记进行基因分析,结果表明与TPO基因存在连锁关系。对其17个外显子及其侧翼内含子-外显子连接区进行测序,发现了先前描述的纯合状态的c.875C>T(p.S292F)突变。在TPO基因启动子的900 bp或PDS基因中均未发现其他突变。计算机分析表明,p.S292F突变可能会减小TPO的催化腔,从而限制潜在底物进入催化口袋。在TPO基因中使用4个单核苷酸多态性(SNP)和一个微卫星标记,发现了一个相关单倍型:G-C-G-G-214,这证明了存在奠基者突变。

结论

这是突尼斯首次描述导致TD的突变,因此可能有助于为研究区域的先天性甲状腺功能减退症制定基因筛查方案。尽管结构模型表明该突变具有致病作用,但仍需要进行功能研究。其他致病和/或修饰基因,以及诊断延迟,可能解释了我们患者中观察到的临床变异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验